USA - NASDAQ:SRRK - US80706P1030 - Common Stock
Taking everything into account, SRRK scores 2 out of 10 in our fundamental rating. SRRK was compared to 534 industry peers in the Biotechnology industry. SRRK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SRRK has a expensive valuation and it also scores bad on growth.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -92.84% | ||
| ROE | -135.32% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 9.29 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.33 | ||
| Quick Ratio | 6.33 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
30.5
+0.82 (+2.76%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 12.57 | ||
| P/tB | 12.57 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -92.84% | ||
| ROE | -135.32% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 32.65% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 6.33 | ||
| Quick Ratio | 6.33 | ||
| Altman-Z | 9.29 |
ChartMill assigns a fundamental rating of 2 / 10 to SRRK.
ChartMill assigns a valuation rating of 0 / 10 to SCHOLAR ROCK HOLDING CORP (SRRK). This can be considered as Overvalued.
SCHOLAR ROCK HOLDING CORP (SRRK) has a profitability rating of 0 / 10.
The financial health rating of SCHOLAR ROCK HOLDING CORP (SRRK) is 5 / 10.
The Earnings per Share (EPS) of SCHOLAR ROCK HOLDING CORP (SRRK) is expected to decline by -36.66% in the next year.